Lidocaína / Epinefrina Dermogen

Lidocaine, the active ingredient in Lidocaína / Epinefrina Dermogen, is a local anesthetic presented as a sterile injectable solution for infiltration use. It provides rapid numbing of targeted tissues and is combined with epinephrine to extend the anesthetic effect and minimize bleeding during procedures.\n\nGNH India supplies Lidocaína / Epinefrina Dermogen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine/Epinephrine is used in the local anesthesia pathway to provide pain control and hemostasis for minor procedures.\n\n- Minor surgical procedures: delivers effective tissue numbness and reduces intra‑operative bleeding.\n- Diagnostic skin biopsies: enables painless removal of skin samples for pathology.\n- Dental procedures: facilitates pain‑free tooth extractions, restorations and periodontal work.

Adverse reactions may occur following infiltration of lidocaine/epinephrine.\n\nCommon Side Effects:\n- Redness or mild swelling at the injection site\n- Transient tingling or numbness beyond the target area\n- Light‑headedness or dizziness\n- Mild headache\n- Nausea\n- Temporary increase in heart rate\n\nSerious or Rare Side Effects:\n- Severe allergic reaction (anaphylaxis)\n- Cardiac arrhythmias or hypertension\n- Methemoglobinemia\n- Seizures\n- Persistent numbness or motor weakness\n- Tissue necrosis at injection site

When using lidocaine/epinephrine, consider the following safety measures.\n\n- Assess patient allergy history: avoid if known hypersensitivity to amide anesthetics or catecholamines.\n- Evaluate cardiovascular status: use caution in patients with uncontrolled hypertension or arrhythmias.\n- Limit total dose: adhere to recommended maximum lidocaine dose to prevent toxicity.\n- Monitor for systemic effects: observe for signs of CNS or cardiac toxicity during and after administration.\n- Use appropriate aseptic technique: maintain sterility to prevent infection.\n- Store at room temperature: keep below 25°C, protect from moisture and direct sunlight.

Lidocaine/epinephrine may interact with several drug classes.\n\nMajor Interactions (Avoid):\n- Beta‑blockers: can potentiate epinephrine‑induced hypertension and tachycardia.\n- Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis with epinephrine.\n- Class I antiarrhythmic drugs: may exacerbate lidocaine‑induced cardiac conduction disturbances.\n\nModerate Interactions (Monitor Closely):\n- Tricyclic antidepressants: may lower seizure threshold when combined with lidocaine.\n- Calcium channel blockers: can enhance negative inotropic effects.\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase bleeding risk when epinephrine’s vasoconstriction is reduced.